Ramy Farid, Schrödinger CEO (Schrödinger)
Bristol Myers fronts new Schrödinger alliance with $55M upfront, expanding precision oncology profile
Bristol Myers Squibb has a new R&D partner, one to which they’re paying a pretty penny to use their discovery platform.
The pharma company is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
